On the Move: INFINITE Names Wiedeke Head of Talent

Why It Matters

These hires signal a heightened focus on people and strategic alignment as firms scale, positioning them to capture growth in competitive markets.

Key Takeaways

• Infinite creates Head of Talent role, hires Eric Wiedeke.
• Wiedeke brings experience from Marina Maher Communications and Delphi Digital.
• Anomaly expands Kira Montgomery to North America strategy director.
• Montgomery will align communications across Anomaly’s U.S. and Canadian offices.
• Jackson Laboratory adds Steven Holstein as SVP of external affairs.

Pulse Analysis

Infinite’s decision to carve out a dedicated Head of Talent reflects a broader industry shift toward treating people strategy as a core growth engine. Eric Wiedeke arrives with a résumé that spans agency communications, digital research, and health‑care firms, positioning him to synchronize hiring, development, and culture with Infinite’s global expansion plans. By institutionalizing talent oversight, Infinite aims to reduce turnover, accelerate client‑service capabilities, and differentiate itself in a crowded PR landscape.

At Anomaly, the promotion of Kira Montgomery to executive strategy director underscores the agency’s push to unify brand storytelling across its North American footprint. Montgomery’s track record of uncovering unconventional angles will now inform cross‑office collaborations among strategy, creative, and media teams. The move promises faster, more cohesive campaign execution for clients seeking integrated communications that resonate across diverse markets, a competitive advantage as brands demand holistic narratives.

The Jackson Laboratory’s appointment of Steven Holstein as SVP of external affairs highlights the growing importance of coordinated outreach in biotech. Holstein’s background in capital formation and partnership development equips the research institution to better align its scientific breakthroughs with funding sources, policy makers, and industry collaborators. A unified external affairs function can accelerate translational research, attract investment, and amplify the lab’s impact on genomic medicine, reinforcing its position at the forefront of life‑science innovation.